ReviewPer Med2023
Long noncoding RNA polymorphisms and hepatocellular carcinoma and pancreatic cancer risk.
- Journal
- Per Med
- Published
- 27 January 2023
- Citations
- 2
- Type
- Review
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Hepatocellular carcinoma (HCC) and pancreatic cancer (PC) are among serious malignancies with no proper biomarker suffering from poor prognosis and late onset. Regulation of long noncoding RNAs (lncRNAs) is disturbed in tumors, making them appropriate diagnostic markers or therapeutic targets in systemic therapies. … Excerpt only: this text is the publisher’s. Read it in full at the source.